DE69717147T2 - Thrombin inhibitoren - Google Patents

Thrombin inhibitoren

Info

Publication number
DE69717147T2
DE69717147T2 DE69717147T DE69717147T DE69717147T2 DE 69717147 T2 DE69717147 T2 DE 69717147T2 DE 69717147 T DE69717147 T DE 69717147T DE 69717147 T DE69717147 T DE 69717147T DE 69717147 T2 DE69717147 T2 DE 69717147T2
Authority
DE
Germany
Prior art keywords
equiv
mmol
arh
solution
arch2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69717147T
Other languages
German (de)
English (en)
Other versions
DE69717147D1 (en
Inventor
E. Fraley
W. Hungate
M. Naylor-Olsen
P. Vacca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625311.7A external-priority patent/GB9625311D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69717147D1 publication Critical patent/DE69717147D1/de
Application granted granted Critical
Publication of DE69717147T2 publication Critical patent/DE69717147T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
DE69717147T 1996-08-12 1997-08-08 Thrombin inhibitoren Expired - Fee Related DE69717147T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2382996P 1996-08-12 1996-08-12
GBGB9625311.7A GB9625311D0 (en) 1996-12-05 1996-12-05 Thrombin inhibitors
PCT/US1997/014019 WO1998006396A1 (en) 1996-08-12 1997-08-08 Thrombin inhibitors

Publications (2)

Publication Number Publication Date
DE69717147D1 DE69717147D1 (en) 2002-12-19
DE69717147T2 true DE69717147T2 (de) 2003-07-24

Family

ID=26310558

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69717147T Expired - Fee Related DE69717147T2 (de) 1996-08-12 1997-08-08 Thrombin inhibitoren

Country Status (8)

Country Link
EP (1) EP0949921B1 (enExample)
JP (1) JP2000516929A (enExample)
AT (1) ATE227571T1 (enExample)
AU (1) AU713527B2 (enExample)
CA (1) CA2262686A1 (enExample)
DE (1) DE69717147T2 (enExample)
ES (1) ES2185042T3 (enExample)
WO (1) WO1998006396A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2406684T3 (es) 2007-08-24 2013-06-07 Marinomed Biotechnologie Gmbh Composición antiviral que comprende un polisacárido sulfatado: iota carragenano
BR112015023214A8 (pt) * 2013-03-15 2019-12-24 Verseon Corp composto, composição farmacêutica, e, uso de um composto ou composição farmacêutica

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6013788A (ja) * 1983-07-05 1985-01-24 Yamanouchi Pharmaceut Co Ltd 新規なクマリン誘導体
EP0446604A3 (en) * 1990-03-16 1992-02-19 American Cyanamid Company Pyridine and related aza heterocycle derivatives as cardiovascular agents
IE912759A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
WO1992008709A1 (de) * 1990-11-15 1992-05-29 Pentapharm Ag Meta-substituierte phenylalanin-derivate
US5399564A (en) * 1991-09-03 1995-03-21 Dowelanco N-(4-pyridyl or 4-quinolinyl) arylacetamide and 4-(aralkoxy or aralkylamino) pyridine pesticides
FR2695387B1 (fr) * 1992-09-09 1994-10-21 Adir Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US6506876B1 (en) * 1994-10-11 2003-01-14 G.D. Searle & Co. LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use

Also Published As

Publication number Publication date
EP0949921B1 (en) 2002-11-13
JP2000516929A (ja) 2000-12-19
ES2185042T3 (es) 2003-04-16
CA2262686A1 (en) 1998-02-19
EP0949921A1 (en) 1999-10-20
AU713527B2 (en) 1999-12-02
ATE227571T1 (de) 2002-11-15
DE69717147D1 (en) 2002-12-19
WO1998006396A1 (en) 1998-02-19
AU3974997A (en) 1998-03-06
EP0949921A4 (enExample) 1999-10-20

Similar Documents

Publication Publication Date Title
US5668289A (en) Pyridinone thrombin inhibitors
DE69528528T2 (de) Thrombin-inhibitoren
US5792779A (en) Pyridinone thrombin inhibitors
AU703744B2 (en) Pyridinone-thrombin inhibitors
US5629324A (en) Thrombin inhibitors
DE69519921T2 (de) Imidazolidin-derivate und ihre verwendung
DE69719775T2 (de) Thrombin inhibitoren
AU741173B2 (en) Substituted N-((aminoiminomethyl or aminomethyl)phenyl) propyl amides
AU720616B2 (en) Pyridinone thrombin inhibitors
US5869487A (en) Pyrido 3,4-B!pyrazines for use as thrombin inhibitors
DE69628856T2 (de) Substituierte n-[(aminoiminomethyl oder aminomethyl)phenyl]propylamide
CN101213184B (zh) 包含不饱和或环状连接基团的杂芳基取代的酰胺及其作为药物的用途
US4873253A (en) Phenylalanine derivative and proteinase inhibitor
JP2001508796A (ja) トロンビン阻害薬
DE60114640T2 (de) Antithrombosemittel
DE69625230T2 (de) Thrombininhibitoren
US5798377A (en) Thrombin inhibitors
US5792761A (en) Thrombin inhibitors
DE69717147T2 (de) Thrombin inhibitoren
US5753667A (en) 1-oxo-2- (phenylsulphonylamino) pentylpiperidine derivatives, their preparation and their therapeutic application
JP2526084B2 (ja) 新規なチアゾリジン誘導体
US6017934A (en) Thrombin inhibitors
US6004976A (en) Thrombin inhibitors

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee